Toggle Nav
Close
  • Menu
  • Setting

Recombinant Human Dkk1

Catalog No.
PH2046
Recombinant Human Dkk1
Grouped product items
SizePriceStock Qty
10ug
$167.00
In stock
100ug
$333.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Dickkopf related protein 1 (Dkk-1) is the founding member of the Dickkopf family of proteins that includes Dkk-1, -2, -3, -4, and a related protein, Soggy [1, 2]. Dkk proteins are secreted proteins that contain two conserved cysteine-rich domains separated by a linker region. Each domain contains ten cysteine residues [1-3]. Mature human Dkk-1 is a 40 kDa glycosylated protein that shares 86%, 87%, 90% and 91% aa sequence identity with mouse, rat, rabbit and bovine Dkk-1, respectively. It also shares 42% and 36% aa identity with human Dkk-2 and Dkk-4, respectively. Dkk-1 and Dkk-4 are well documented antagonists of the canonical Wnt signaling pathway [1, 2]. This pathway is activated by Wnt engagement of a receptor complex composed of the Frizzled proteins and one of two low-density lipoprotein receptor-related proteins, LRP5 or LRP6 [4]. Dkk-1 antagonizes Wnt by forming ternary complexes of LRP5/6 with Kremen1 or Kremen2 [4, 5]. Dkk-1/LRP6/Krm2 complex internalization has been shown to down-regulate Wnt signaling [4, 5]. Dkk-1 is expressed throughout development and antagonizes Wnt-7a during limb development [6, 7]. Other sites of expression include developing neurons, hair follicles and the retina of the eye [8, 9]. The balance between Wnt signaling and Dkk-1 inhibition is critical for bone formation and homeostasis [10]. Insufficient or excess Dkk-1 activity in bone results in increased or decreased bone density, respectively [8, 11]. In adults, Dkk-1 is expressed in osteoblasts and osteocytes, and neurons. Cerebral ischemia induces Dkk-1 expression, which contributes to neuronal cell death [12].

Reference

[1]. Krupnik, V.E. et al. (1999) Gene 238:301.

[2]. Niehrs, C. (2006) Oncogene 25:7469.

[3]. Bullock, C.M. et al. (2004) Mol. Pharmacol. 65:582.

[4]. Mao, B. et al. (2001) Nature 411:321.

[5]. Mao, B. et al. (2002) Nature 417:664.

[6]. Kemp, C. et al. (2005) Dev. Dyn. 233:1064.

[7]. Adamska, M. et al. (2004) Dev. Biol. 272:134.

[8]. Li, J. et al. (2006) Bone 36:754.

[9]. Verani, R. et al. (2006) J. Neurochem. 101:242.

[10]. Pinzone, J.J. et al. (2009) Blood 113:517.

[11]. Morvan, F. et al. (2006) J. Bone Miner. Res. 21:934.

[12]. Cappuccio, I. et al. (2005) J. Neurosci. 25:2647.

Description

Accession #

O94907

Alternate Names

Dickkopf-1; dickkopf-related protein 1; Dkk1; Dkk-1; hDkk-1; SKdickkopf-1 like

Source

Human embryonic kidney cell, HEK293-derived human Dkk1 protein

Protein sequence

Met 2-His 266

M.Wt

26.6 kDa

Appearance

Solution protein.

Stability & Storage

Avoid repeated freeze-thaw cycles. It is recommended that the protein be aliquoted for optimal storage. 3 years from date of receipt, -20 to -70 °C as supplied.

Concentration

0. 2 mg/mL

Formulation

Dissolved in sterile PBS buffer.

Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers.

Biological Activity

Measured by its ability to inhibit Wnt induced TCF reporter activity in HEK293 human embryonic kidney cells. The EC50 for this effect is approximately 1-8 ng/ml.

Shipping Condition

Shipping with dry ice.

Handling

Centrifuge the vial prior to opening.

Usage

For Research Use Only! Not to be used in humans.

Quality Control

Quality Control & DataSheet

View current batch:
    Purity > 95%, determined by SDS-PAGE.
    Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.
  • Datasheet